Articles with public access mandates - Xiaokui MoLearn more
Not available anywhere: 3
Magnetic resonance elastography of the pancreas: Measurement reproducibility and relationship with age
A Kolipaka, S Schroeder, X Mo, Z Shah, PA Hart, DL Conwell
Magnetic resonance imaging 42, 1-7, 2017
Mandates: US National Institutes of Health, American Heart Association
Type of TP53 mutation influences oncogenic potential and spectrum of associated K‐ras mutations in lung‐specific transgenic mice
W Duan, L Gao, A Kalvala, B Aguila, C Brooks, X Mo, H Ding, K Shilo, ...
International Journal of Cancer 145 (9), 2418-2426, 2019
Mandates: US National Institutes of Health
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
S Khountham, P Shindiapina, X Mo, C Lachowiez, T Wiczer, L Mousa, ...
Leukemia & Lymphoma 62 (3), 716-721, 2021
Mandates: US National Institutes of Health
Available somewhere: 161
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
X Zhu, M Badawi, S Pomeroy, DS Sutaria, Z Xie, A Baek, J Jiang, ...
Journal of extracellular vesicles 6 (1), 1324730, 2017
Mandates: US National Institutes of Health
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
R Lapalombella, Q Sun, K Williams, L Tangeman, S Jha, Y Zhong, ...
Blood, The Journal of the American Society of Hematology 120 (23), 4621-4634, 2012
Mandates: US National Institutes of Health
Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis
F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ...
Clinical Cancer Research 22 (21), 5337-5348, 2016
Mandates: US National Institutes of Health
Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10
JL Voorhees, AJ Tarr, ES Wohleb, JP Godbout, X Mo, JF Sheridan, ...
PloS one 8 (3), e58488, 2013
Mandates: US National Institutes of Health
MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells
K Joshi, Y Banasavadi-Siddegowda, X Mo, SH Kim, P Mao, C Kig, ...
Stem cells 31 (6), 1051-1063, 2013
Mandates: US National Institutes of Health
Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress
X Cheng, F Geng, M Pan, X Wu, Y Zhong, C Wang, Z Tian, C Cheng, ...
Cell metabolism 32 (2), 229-242. e8, 2020
Mandates: US National Institutes of Health
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma
F Yan, L Alinari, ME Lustberg, L Katherine Martin, HM Cordero-Nieves, ...
Cancer research 74 (6), 1752-1765, 2014
Mandates: US National Institutes of Health
AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt–MDM2–Foxo3a signaling axis
CC Chou, KH Lee, IL Lai, D Wang, X Mo, SK Kulp, CL Shapiro, CS Chen
Cancer research 74 (17), 4783-4795, 2014
Mandates: US National Institutes of Health
Canonical and atypical E2Fs regulate the mammalian endocycle
HZ Chen, MM Ouseph, J Li, T Pécot, V Chokshi, L Kent, S Bae, M Byrne, ...
Nature cell biology 14 (11), 1192-1202, 2012
Mandates: US National Institutes of Health
Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia
J Yu, Y Peng, LC Wu, Z Xie, Y Deng, T Hughes, S He, XK Mo, M Chiu, ...
PloS one 8 (2), e55934, 2013
Mandates: US National Institutes of Health
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals
R Lapalombella, YY Yeh, L Wang, A Ramanunni, S Rafiq, S Jha, J Staubli, ...
Cancer cell 21 (5), 694-708, 2012
Mandates: US National Institutes of Health
Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine
LE Arnold, RA DiSilvestro, D Bozzolo, H Bozzolo, L Crowl, S Fernandez, ...
Journal of child and adolescent psychopharmacology 21 (1), 1-19, 2011
Mandates: US National Institutes of Health, Autism Speaks Inc, USA
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
EM McWilliams, JM Mele, C Cheney, EA Timmerman, F Fiazuddin, ...
Oncoimmunology 5 (10), e1226720, 2016
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody
FT Awan, R Lapalombella, R Trotta, JP Butchar, B Yu, DM Benson Jr, ...
Blood, The Journal of the American Society of Hematology 115 (6), 1204-1213, 2010
Mandates: US National Institutes of Health
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway
R Lapalombella, L Andritsos, Q Liu, SE May, R Browning, LV Pham, ...
Blood, The Journal of the American Society of Hematology 115 (13), 2619-2629, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer
EH Bell, AR Chakraborty, X Mo, Z Liu, K Shilo, S Kirste, P Stegmaier, ...
Clinical Cancer Research 22 (10), 2396-2404, 2016
Mandates: US National Institutes of Health
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties
S Rafiq, JP Butchar, C Cheney, X Mo, R Trotta, M Caligiuri, D Jarjoura, ...
The Journal of Immunology 190 (6), 2702-2711, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program